UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview

Therapeutic delivery, 2014-06, Vol.5 (6), p.709-733

2014

Volltextzugriff (PDF)

NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis

Journal of allergy and clinical immunology, 2019-01, Vol.143 (1), p.126-134.e5

2019

Volltextzugriff (PDF)

NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps

American journal of rhinology & allergy, 2019-01, Vol.33 (1), p.69-82

2019

Volltextzugriff (PDF)

A Randomized Comparison of the Pharmacokinetics and Bioavailability of Fluticasone Propionate Delivered via Xhance Exhalation Delivery System Versus Flonase Nasal Spray and Flovent HFA Inhalational Aerosol

Clinical therapeutics, 2019-11, Vol.41 (11), p.2343-2356

2019

Volltextzugriff (PDF)

A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis

Allergy and asthma proceedings, 2019-01, Vol.40 (1), p.48-56

2019

Volltextzugriff (PDF)

Role of nasal casts for in vitro evaluation of nasal drug delivery and quantitative evaluation of various nasal casts

Therapeutic delivery, 2020-08, Vol.11 (8), p.485-495

2020

Volltextzugriff (PDF)

Exhalation Delivery Systems (EDS) Greatly Increase Topical Delivery to Target Sites for Chronic Rhinosinusitis (CRS) Compared to Nasal Sprays or Pressurized MDIs (pMDI)

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB274-AB274

2018

Volltextzugriff (PDF)

Accessing the Brain: The Nose may Know the Way

Journal of cerebral blood flow and metabolism, 2013-05, Vol.33 (5), p.793-794

2013

Volltextzugriff (PDF)

EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis

International forum of allergy & rhinology, 2018-08, Vol.8 (8), p.869-876

2018

Volltextzugriff (PDF)

EDS-FLU performs differently than other nasal corticosteroids

Journal of allergy and clinical immunology, 2019-07, Vol.144 (1), p.349-349

2019

Volltextzugriff (PDF)

Lifetime Work Productivity Gains Among Patients with Chronic Rhinosinusitis with Nasal polyps (CRSwNP) Treated with EDS-FLU

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB281-AB281

2019

Volltextzugriff (PDF)

Exhalation Delivery System with Fluticasone (EDS-FLU) Improves Outcomes in Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) in Patients With or Without Recent Intranasal Steroid Use

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB169-AB169

2018

Volltextzugriff (PDF)

EDS-FLU Improves Quality of Life and Health Status: Pooled Analysis of Phase 3 Trials Navigate I and II

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB163-AB163

2018

Volltextzugriff (PDF)

Evidence is Limited for the Efficacy and Safety of Corticosteroid Irrigation in Chronic Rhinosinusitis (CRS)

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB282-AB282

2019

Volltextzugriff (PDF)

Evidence for Twice-Daily Nasal Steroids Versus Once Daily for Treatment of Chronic Rhinosinusitis with Nasal Polyps

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB283-AB283

2019

Volltextzugriff (PDF)

Exhalation Delivery System (EDS) Intranasal Steroid vs Conventional Inhaled Nasal Steroids (INS): Patient Preference, Comfort and Ease of Use

Journal of allergy and clinical immunology, 2019-02, Vol.143 (2), p.AB63

2019

Volltextzugriff (PDF)

Disease Burden of Chronic Rhinosinusitis (CRS) is as Severe as Other Serious Chronic Diseases

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB165-AB165

2018

Volltextzugriff (PDF)

Exhalation Delivery System with Fluticasone (EDS-FLU) Improves Health-Related Quality of Life (HRQoL) in Patients with Chronic Rhinosinusitis with Nasal Polyps: Results from NAVIGATE II

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB166-AB166

2018

Volltextzugriff (PDF)

A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis

Allergy and asthma proceedings, 2018-11

2018

Volltextzugriff (PDF)

EDS‐FLU: An important step in appropriate medical therapy for chronic rhinosinusitis with nasal polyps

International forum of allergy & rhinology, 2022-06, Vol.12 (6), p.893-895

2022

Volltextzugriff (PDF)

Economic Impact Associated with a Reduction in Surgical Eligibility among Adult Patients with Chronic Rhinosinusitis - A Population Cost Offset Model

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB165-AB165

2018

Volltextzugriff (PDF)

Development of computational fluid dynamics methodology for characterization of exhalation delivery system performance in a nasal airway with Draf-III surgery

Journal of aerosol science, 2023-03, Vol.169, p.106121, Article 106121

2023

Volltextzugriff (PDF)

Deposition of drugs in the nose and sinuses with an exhalation delivery system vs conventional nasal spray or high-volume irrigation in Draf II/III post-surgical anatomy

Rhinology, 2020-04, Vol.58 (2), p.175-183

2020

Volltextzugriff (PDF)

Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications

International journal of geriatric psychiatry, 2000-03, Vol.15 (3), p.242-247

2000

Volltextzugriff (PDF)

EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps

Rhinology, 2020-02, Vol.58 (1), p.25-35

2020

Volltextzugriff (PDF)

1 – 25 von 168

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Englisch
(168)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview

NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis

NAVIGATE I: Randomized, Placebo-Controlled, Double-Blind Trial of the Exhalation Delivery System With Fluticasone for Chronic Rhinosinusitis With Nasal Polyps

A Randomized Comparison of the Pharmacokinetics and Bioavailability of Fluticasone Propionate Delivered via Xhance Exhalation Delivery System Versus Flonase Nasal Spray and Flovent HFA Inhalational Aerosol

A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis

Role of nasal casts for in vitro evaluation of nasal drug delivery and quantitative evaluation of various nasal casts

Exhalation Delivery Systems (EDS) Greatly Increase Topical Delivery to Target Sites for Chronic Rhinosinusitis (CRS) Compared to Nasal Sprays or Pressurized MDIs (pMDI)

Accessing the Brain: The Nose may Know the Way

EXHANCE‐12: 1‐year study of the exhalation delivery system with fluticasone (EDS‐FLU) in chronic rhinosinusitis

EDS-FLU performs differently than other nasal corticosteroids

Lifetime Work Productivity Gains Among Patients with Chronic Rhinosinusitis with Nasal polyps (CRSwNP) Treated with EDS-FLU

Exhalation Delivery System with Fluticasone (EDS-FLU) Improves Outcomes in Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) in Patients With or Without Recent Intranasal Steroid Use

EDS-FLU Improves Quality of Life and Health Status: Pooled Analysis of Phase 3 Trials Navigate I and II

Evidence is Limited for the Efficacy and Safety of Corticosteroid Irrigation in Chronic Rhinosinusitis (CRS)

Evidence for Twice-Daily Nasal Steroids Versus Once Daily for Treatment of Chronic Rhinosinusitis with Nasal Polyps

Exhalation Delivery System (EDS) Intranasal Steroid vs Conventional Inhaled Nasal Steroids (INS): Patient Preference, Comfort and Ease of Use

Disease Burden of Chronic Rhinosinusitis (CRS) is as Severe as Other Serious Chronic Diseases

Exhalation Delivery System with Fluticasone (EDS-FLU) Improves Health-Related Quality of Life (HRQoL) in Patients with Chronic Rhinosinusitis with Nasal Polyps: Results from NAVIGATE II

A cross-sectional, population-based survey of U.S. adults with symptoms of chronic rhinosinusitis

EDS‐FLU: An important step in appropriate medical therapy for chronic rhinosinusitis with nasal polyps

Economic Impact Associated with a Reduction in Surgical Eligibility among Adult Patients with Chronic Rhinosinusitis - A Population Cost Offset Model

Development of computational fluid dynamics methodology for characterization of exhalation delivery system performance in a nasal airway with Draf-III surgery

Deposition of drugs in the nose and sinuses with an exhalation delivery system vs conventional nasal spray or high-volume irrigation in Draf II/III post-surgical anatomy

Lack of adverse pharmacodynamic drug interactions with rivastigmine and twenty-two classes of medications

EXHANCE-3: a cohort study of the exhalation delivery system with fluticasone for chronic sinusitis with or without nasal polyps

Suchergebnisse filtern